The troubling increase in treatment resistance in psychiatry has many culprits: the rise of biomedical psychiatry and corresponding sidelining of psychodynamic and psychosocial factors; the increased emphasis on treating the symptoms rather than the person; and a greater focus on the electronic medical record rather than the patient, all of which point to a breakdown in the person-centered prescriber–patient relationship.
Psychodynamic Psychopharmacology illuminates a new path forward. It examines the psychological and interpersonal mechanisms of pharmacological treatment resistance, integrating research on evidence-based prescribing processes with psychodynamic insights and skills to enhance treatment outcomes for patients who are difficult to treat.
The first part of the book explores the evidence base that guides how, rather than simply what, to prescribe. It describes precisely what psychodynamic psychopharmacology is and why its emphasis on combining the often-neglected psychosocial aspects of medication with biomedical considerations provides a more optimized approach to addressing treatment resistance.
Part II delves into the psychodynamics that contribute to pharmacological treatment resistance, both when patients ambivalence about their illness, the medication itself, or their prescriber manifests in nonadherence and when medications support a negative identity or are used as replacements for healthy capacities. Readers will gain basic skills for addressing the psychological and interpersonal dynamics that underpin both scenarios and will be better positioned to ameliorate interferences with the healthy use of medications.
The final section of the book offers detailed technical recommendations for addressing pharmacological treatment resistance. It tackles issues that include countertransference-driven irrational prescribing; primitive dynamics, such as splitting and projective identification; and the overlap between psychopharmacological treatment resistance and the dynamics of treatment nonadherence and nonresponse in integrated and collaborative medical care settings.
By putting the individual patient back at the center of the therapeutic equation, psychodynamic psychopharmacology, as outlined in this book, offers a model that moves beyond compliance and emphasizes instead the alliance between patient and prescriber. In doing so, it empowers patients to become more active contributors in their own recovery.
Dr. David Mintz has done a great service in this excellent book for those who prescribe psychiatric medications: he has provided an important approach to optimizing treatment outcomes by integrating pharmacotherapy with a psychodynamically-informed perspective that enhances therapeutic factors for the patient and in the doctor-patient encounter. Through clinical examples and literature review he has defined what many clinicians have learned through experience but were not taught as part of their psychopharmacology education. The interpersonal context of the prescribing relationship between prescriber and patient may have deep psychodynamic meaning to many patients. Understanding these factors (such as transference to parental figures) can enhance the adherence and effectiveness of treatments. I recommend this book for all psychopharmacology prescribers.—Carl Salzman M.D., Professor of Psychiatry Harvard Medical School
Preface
Part 1. What Is Psychodynamic Psychopharmacology?
Chapter 1. What Is Psychodynamic Psychopharmacology?
Chapter 2. Why Psychodynamic Psychopharmacology?
Chapter 3. What Is Psychodynamic About Psychodynamic Psychopharmacology?
Part 2. Understanding Pharmacological Treatment Resistance
Chapter 4. Psychodynamics of Pharmacological Treatment Resistance
Chapter 5. Treatment Resistance to Medications
Chapter 6. Treatment Resistance From Medications
Chapter 7. The Prescribers Contribution to Treatment Resistance
Part 3. The Manual of Psychodynamic Psychopharmacology
Chapter 8. Avoid a Mind-Body Split
Chapter 9. Know Who the Patient Is
Chapter 10. Attend to Patients Ambivalence
Chapter 11. Cultivate the Pharmacotherapeutic Alliance
Chapter 12. Attend to Countertherapeutic Uses of Medications
Chapter 13. Identify, Contain, and Use Countertransference
Chapter 14. Who Is Psychodynamic Psychopharmacology For? Patient Characteristics
Chapter 15. Before Initiating Treatment
Chapter 16. The Engagement Phase
Chapter 17. The Maintenance Phase
Chapter 18. Split and Combined Treatments
Chapter 19. Psychodynamic Psychopharmacology and Integrated Care
